The treatment of osteosarcoma, the most common tumor of bone, is challenging. A new study found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.
The treatment of osteosarcoma, the most common tumor of bone, is challenging. A new study found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.